BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1352860 BLUE BELL, PA

Position in NTLA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$29,728

+$7,204 QoQ

Shares Held

1,757

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#255

of 329 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 60% Shared 0% None 40%

Healthcare · as of Jun 30, 2026

BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC holds $146,305 across 4 Biotechnology names. NTLA ranks #2 (20.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRME	Prime Medicine, Inc.	25,830	$95,312
2	NTLA	Intellia Therapeutics, Inc. This page	1,757	$29,728
3	INCY	Incyte Corp	139	$15,757
4	CRSP	CRISPR Therapeutics AG	101	$5,508

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,728	1,757	0.0%	Shares	Sole	2026-08-06
2026-03-31	$22,524	1,757	0.0%	Shares	Sole	2026-05-11
2025-12-31	$15,795	1,757	0.0%	Shares	Sole	2026-02-09
2025-09-30	$30,343	1,757	—	Shares	Sole	2025-10-22
No filing history on record for this holder in this stock.